FDA Approves First Single-Dose Antibiotic For Dogs, Cats

Pfizer Animal Health’s antibiotic Convenia has been approved by the FDA.

The U.S. Food and Drug Administration has approved Pfizer Animal Health’s Convenia (cefovecin sodium), the first antibiotic for dogs and cats available in a single injectable dose.

The product, which provides  up to 14 days of antibiotic treatment for the most common skin infections in dogs and cats, will eliminate the difficulty owners have giving pills to pets and will ensure the course of reatment is completed on time, according to the company.

“We understand how difficult it can be for owners to give their pets the right pills at the right time,” said George Fennell, vice president, Companion Animal Division, Pfizer Animal Health. 

“With career and family responsibilities, many people simply aren’t around at appropriate intervals once, twice or even more times a day despite their best intentions. With Convenia, the pet gets the dose it needs right in the veterinarian’s office—so owners don’t have to worry about when and how to give pills to their pets.”

The most common side effects are similar to those seen with other antibiotics, such as vomiting, diarrhea, decreased appetite and lethargy.

Pfizer Animal Health is based in New York.


Leave a Comment


Your email address will not be published. Required fields are marked *


Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.